Watertown, Mass.-based CRO New England Research Institutes (NERI) established a strategic partnership with Evidence Clinical and Pharmaceutical Research Institute, a CRO which focuses on conducting trials in Russia and Eastern Europe. Evidence is headquartered in Saint-Petersburg, Russia, and has offices in Los Altos, Calif., and Swampscott, Mass. The companies stated that both Eastern Europe and Russia are becoming increasingly popular regions for conducting clinical trials, and sponsors are creating an ever larger presence there.
“In addition to our North American depth, we have established a consortium of strategic CRO partners in emerging locations. The Evidence team fits well within our mix of employees and partners because they offer excellent data quality, high recruitment rates, well-trained and experienced personnel, and advanced communication technologies,” stated Rebecca Li, Ph.D., NERI’s vice president of clinical research.